SCLX

Scilex Holding Company Common Stock (SCLX)

Stock · NASDAQ · Health Care

$2.81as of 10/16/2026

Active signals

High Beta40.2%
200 SMA Touch0.0%
Resistance level
$4.17
Industry
Biotechnology: Biological Products (No Diagnostic Substances)

What SCLX's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.

SignalTimesMedian 20-session returnHigher after 20 sessions
Volume Spike35-18.7%26%
Bollinger Band Breakout21-8.8%38%
Bollinger Band Breakdown17-20.3%24%
200-Day Moving Average TouchActive now5-10.6%40%
Any 20-session window (baseline)-7.9%41%

Computed by MarketWall from daily closing prices since May 18, 2022. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.

About SCLX

Scilex Holding Company focuses on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. Its commercial products include ZTlido (lidocaine topical system) 1.8% (ZTlido), a prescription lidocaine topical product for the relief of neuropathic pain associated with postherpetic neuralgia (PHN), which is a form of post-shingles nerve pain; ELYXYB, a read…

Sector
Health Care
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Employees
34

Fundamentals

1-day range
$2.77$2.89
Market cap
$58.93M
P/E (trailing)
—
P/E (forward)
3.88
EPS (trailing)
$-48.45
Dividend yield
—
Beta
1.83
Avg. volume
52.3K
52-week range
$2.77$27
Next earnings: March 12, 2026 · EPS estimate $-0.47confirmed

How Scilex Holding Company Common Stock Makes Money

Where the revenue actually goes — FY2025 annual results

market-wall.comTotalRevenue$30.30MSG&A$266.88M (881%)R&D$20.71M (68%)Cost of Revenue$10.60M (35%)Tax$26.0K (0%)SCLX

Source: 10-K filed Apr 10, 2026 · via SEC EDGAR / Finnhub

Gross Profit$19.70M(65%)
Operating Income-$346.00M(-1142%)

Scilex Holding Company Common Stock Competitors

Chosen by industry and closest market cap.

  • SCLX
    Scilex Holding Company Common Stock
    $2.83
    ▲ 0.35%
    Market cap $58.93MP/E —
    $2.77$27
  • INKT
    MiNK Therapeutics Inc. Common Stock
    $9.41
    ▼ 5.33%
    Market cap $54.80MP/E —
    $8.48$16.93
  • GNTA
    Genenta Science S.p.A. American Depositary Shares
    $0.675
    ▲ 0.90%
    Market cap $63.16MP/E —
    $0.55$10
  • IMA
    ImageneBio Inc. Common Stock
    $4.04
    ▲ 0.25%
    Market cap $63.50MP/E —
    $3.9$9.1
  • OKYO
    OKYO Pharma Limited Ordinary Shares
    $1.41
    ▼ 1.40%
    Market cap $51.94MP/E —
    $1.26$3.2
  • INMB
    INmune Bio Inc. Common stock
    $1.57
    ▼ 4.85%
    Market cap $50.78MP/E —
    $1.09$2.6
  • TCRX
    TScan Therapeutics Inc. Common Stock
    $0.231
    ▼ 3.35%
    Market cap $49.88MP/E —
    $0.2243$2.57

P/E shows — for peers not currently carrying a live signal of their own.

Latest news

Insider Activity

Insider Actions →
Acquired
3.90M
Disposed
1.15M

Institutional Ownership

March 31, 2026

Total shares held
829.2K
Total value held
$5.52M
Institutional holders
68
Top holders this quarter
  • Unknown297.7K
  • Unknown264.1K
  • Unknown102.8K
  • Unknown36.9K
  • Unknown35.4K
  • Unknown22.6K
  • Unknown18.0K
  • Unknown15.0K
  • Unknown12.0K
  • Unknown9.0K

See the full, filterable feed with live charts on the MarketWall dashboard.

We use analytics to understand how market-wall is used. No personal data is sold.